Axa’s Amneal Pharmaceuticals AMRX Stock Holding History

Axa’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-239,333	Closed	-$1.45M	–	1063
2024 Q1	$1.45M	Hold	239,333	–	–	﹤0.01%	800
2023 Q4	$1.45M	Buy	+239,333	New	+$1.07M	﹤0.01%	787

Other funds holding AMRX

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Axa's AMRX Position: Q2 2024 in Review

Axa sold out of Amneal Pharmaceuticals (AMRX) in Q2 2024, closing a stake of 239,333 shares — an estimated $1.45M sold.

Axa first reported a position in AMRX in Q4 2023 and held it in 2 quarters. The position peaked at $1.45M in Q4 2023. 181 funds tracked by Wall St. Rank hold AMRX as of Q2 2024.

Axa reported no remaining Amneal Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
Axa sold 239,333 Amneal Pharmaceuticals shares in Q2 2024, an estimated $1.45M.
Axa first reported a position in Amneal Pharmaceuticals in Q4 2023 and held it in 2 quarters.
Axa's Amneal Pharmaceuticals position peaked at $1.45M in Q4 2023.
181 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2024.

Based on Axa's 13F filing for Q2 2024, filed 14 Aug 2024.